SABCS2020: Robust survival outcome in HER2 positive metastatic breast cancer
Hear Shanu Modi, Memorial Sloan Kettering Cancer Center, New York, presents the updated results of treatment with trastuzumab deruxtecan in patients with HER2 positive metastatic breast cancer.